CN106834437A - A kind of fragile X mental retardation quick detection kit - Google Patents
A kind of fragile X mental retardation quick detection kit Download PDFInfo
- Publication number
- CN106834437A CN106834437A CN201611214263.8A CN201611214263A CN106834437A CN 106834437 A CN106834437 A CN 106834437A CN 201611214263 A CN201611214263 A CN 201611214263A CN 106834437 A CN106834437 A CN 106834437A
- Authority
- CN
- China
- Prior art keywords
- fragile
- detection kit
- quick detection
- mental retardation
- amplified production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a kind of fragile X mental retardation quick detection kit.A kind of fragile X mental retardation quick detection kit, including:1)The design gene 5' ends non-translational regions of FMR 1(CGG duplicate blocks)Sense primer and anti-sense primer;2)Upstream and downstream primer and high-fidelity enzyme, 10 × PCR buffer etc. mix, and enter performing PCR amplification;3)Amplified production is carried out into agarose electrophoresis, the substantially copy number of CGG is judged by judging the clip size of amplified production, so as to judge whether tester is fragile X syndrome patient or carrier.The amplified production fragment of normal person<300bp, if in the presence of>The amplified production of 700bp, then be premutation person or full mutation person.The design of primers difficulty used in detection method of the invention is low, significantly reduces the cost of primer synthesis;The agarose electrophoresis method judged result of use, further reduces testing cost, substantially increases Clinical practicability.
Description
Technical field
The present invention relates to biological technical field, more particularly to a kind of fragile X mental retardation quick detection kit.
Background technology
Fragile X syndrome causes patient's amentia(Martin-Bell syndromes), it is that a kind of clinical manifestation is mainly
The x linked recessive genetic disease of feeblemindedness, most of mechanism of causing a disease is FMR-1 gene 5' ends non-translational region(CGG)n
Three nucleic acids repeat sequence transmission extremely and cause.Normal person's(CGG)Repeat copy number and be about 30 copies(90bp), and women
The copy number that repeats of carrier and normal male transmitter increases to 150 ~ 500bp, is referred to as premutation, and adjacent CpG islands are not
It is methylated, this premutation(premutation)Nothing or only light symptoms.Full mutation is converted into by premutation mother only occurs
Parent is in offspring's transmittance process:The CGG areas of female carrier are unstable, can cause fragile site high in offspring's transmittance process
The female carrier and male patient of expression increase to 1000 ~ 3000bp, and adjacent CpG islands are also methylated, this full mutation
The expression of neighboring gene can be closed, so as to clinical symptoms occur.
The incidence of disease of fragile X syndrome is about 1/1200 ~ 1/2500 in males, in women population
About 1/2000.And the performance of the complicated clinical manifestation of fragile X syndrome, particularly female carrier is not obvious, hold
Easily increase newborn infant.Presently mainly by genetic counselling and the reduction of pre-natal diagnosis means, the birth of the newborn infant of prevention, from
And reduce the incidence of disease of fragile X mental retardation.
To reduce the incidence of disease of fragile X mental retardation, according to the understanding to fragile site DNA sequence dna, can be connected with RFLP
The methods such as lock analysis, DNA hybridization analysis, real-time fluorescence quantitative PCR amplification detect Disease-causing gene, but all because costly, or
Time-consuming etc. that reason limits its application for person.A kind of fragile X mental retardation quick detection kit of the invention avoids prior art
Shortcoming, it can be by detecting the copy number of the CGG of FMR-1 genes, so as to quickly, accurately judge whether tester is fragility
X chromosome syndrome patient or carrier, reduce Newborn Birth-defects rate, are that the prenatal and postnatal care engineering in the whole nation contributes.
The content of the invention
It is an object of the invention to provide a kind of fragile X mental retardation quick detection kit.
The technical solution used in the present invention is:
1) design is directed to FMR-1 gene 5' ends non-translational region(CGG duplicate blocks)Sense primer and anti-sense primer.
2) upstream and downstream primer and high-fidelity enzyme, 10 × PCR buffer etc. are mixed, is expanded.
3) amplified production is carried out into agarose electrophoresis, CGG is judged substantially by judging the clip size of amplified production
Copy number, so as to judge whether tester is fragile X syndrome patient or carrier.The amplified production fragment of normal person
<300bp, if in the presence of>The amplified production of 700bp, then be premutation person or full mutation person.
As the further improvement of the above method, PCR synergist is with the addition of in PCR system, promote primer-masterplate annealing
And aid in archaeal dna polymerase to extend through secondary structure area.
Particularly, a kind of sequence of the primer of above-mentioned fragile X mental retardation quick detection kit is as follows:
F:5'-GCTCAGCTCCGTTTCGGTT-3'
R:5'-ATTGGAGCCCCGCACTTC-3'
Brief description of the drawings
Fig. 1 is the agarose electrophoresis figure of the DNA cloning product of normal person and fragile X mental retardation patient.Distinguish from left to right
It is passage 1 ~ 7.Passage 1~3 is the DNA cloning product of fragile X syndrome patient;Passage 4~6 is normal person's DNA cloning product;
Passage 7 is 100bp Marker.
Specific embodiment
Embodiment 1:A kind of compound method of fragile X mental retardation quick detection kit
1st, primer:Repeat to go to design primer, including sense primer F and anti-sense primer R in the CGG of FRM-1 genes.
2、10×PCR buffer:Its component mainly includes the Tris-AC of 50mM(pH9.2), the KAC of 50mM, 20mM's
(NH4)2SO4, the MgCl of 10mM2。
Embodiment 2:Using QIAamp DNA Blood Mini Kit (the 50)-reagent of article No. 51104 of QIAGEN companies
Box carries out nucleic acid extraction, obtains sample to be checked.
Embodiment 3:Detection sample
Use the PCR amplification system of embodiment 1:
Tris-AC(pH9.2) | 50mM |
KAC | 50mM |
20mM | |
10mM | |
dNTPs | 300μM |
High-fidelity enzyme | 4U |
DMSO | 6% |
Glycine betaine | 5M |
F | 10pmol |
R | 10pmol |
DNA | 50ng |
Its PCR amplification condition:
After reaction terminates, PCR primer is carried out into agarose electrophoresis, it can be seen that normal person exists<There is clear band at 300bp(Figure
1), and fragile X mental retardation patient exists>There is clear band at 700bp(Fig. 1).This result illustrates that this kit can be with quick detection
Fragile X mental retardation.
SEQUENCE LISTING
<110>Guangzhou two kinds of substance synthesis into another Technology Co., Ltd.
<120>A kind of fragile X mental retardation quick detection kit
<130> 2016
<160> 2
<170> PatentIn version 3.5
<210> 1
<211> 19
<212> DNA
<213>Artificial sequence
<400> 1
gctcagctcc gtttcggtt 19
<210> 2
<211> 18
<212> DNA
<213>Artificial sequence
<400> 2
attggagccc cgcacttc 18
Claims (5)
1. a kind of fragile X syndrome quick detection kit, including:Expand the sense primer F of the CGG duplicate blocks of FMR-1 genes
With anti-sense primer R;High-fidelity enzyme;10 × PCR buffer etc..
2. it is respectively according to the sense primer F and anti-sense primer R described in claim 1:
F:5'-GCTCAGCTCCGTTTCGGTT-3'
R:5'-ATTGGAGCCCCGCACTTC-3'。
3. PCR amplification system according to claim 1 is:
。
4. a kind of PCR amplification conditions of fragile X syndrome quick detection kit according to claim 1 are:
。
5. a kind of judged result method of fragile X syndrome quick detection kit according to claim 1 is agarose
Electrophoresis.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611214263.8A CN106834437A (en) | 2016-12-26 | 2016-12-26 | A kind of fragile X mental retardation quick detection kit |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611214263.8A CN106834437A (en) | 2016-12-26 | 2016-12-26 | A kind of fragile X mental retardation quick detection kit |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106834437A true CN106834437A (en) | 2017-06-13 |
Family
ID=59136307
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611214263.8A Withdrawn CN106834437A (en) | 2016-12-26 | 2016-12-26 | A kind of fragile X mental retardation quick detection kit |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106834437A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108866176A (en) * | 2017-07-11 | 2018-11-23 | 北京阅微基因技术有限公司 | The detection architecture and detection kit of a kind of pair of FMR1 gene 5 ' non-translational region CGG unit number of iterations |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101871001A (en) * | 2009-04-22 | 2010-10-27 | 中山大学达安基因股份有限公司 | Kit for detecting fragile X syndrome |
CN102242187A (en) * | 2010-05-11 | 2011-11-16 | 北京康为世纪生物科技有限公司 | PCR (polymerase chain reaction) detection method for CGG repeat number of FMR1 (fragile X mental retardation 1) gene 5' terminal noncoding region |
WO2014015273A1 (en) * | 2012-07-20 | 2014-01-23 | Asuragen, Inc. | Comprehensive fmr1 genotyping |
CN103981254A (en) * | 2014-03-27 | 2014-08-13 | 江苏佰龄全基因生物医学技术有限公司 | Clinic rapid PCR detection kit of fragile X syndrome |
-
2016
- 2016-12-26 CN CN201611214263.8A patent/CN106834437A/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101871001A (en) * | 2009-04-22 | 2010-10-27 | 中山大学达安基因股份有限公司 | Kit for detecting fragile X syndrome |
CN102242187A (en) * | 2010-05-11 | 2011-11-16 | 北京康为世纪生物科技有限公司 | PCR (polymerase chain reaction) detection method for CGG repeat number of FMR1 (fragile X mental retardation 1) gene 5' terminal noncoding region |
WO2014015273A1 (en) * | 2012-07-20 | 2014-01-23 | Asuragen, Inc. | Comprehensive fmr1 genotyping |
CN103981254A (en) * | 2014-03-27 | 2014-08-13 | 江苏佰龄全基因生物医学技术有限公司 | Clinic rapid PCR detection kit of fragile X syndrome |
Non-Patent Citations (1)
Title |
---|
王旻等: "《生物工程》", 30 August 2015, 北京:中国医药科技出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108866176A (en) * | 2017-07-11 | 2018-11-23 | 北京阅微基因技术有限公司 | The detection architecture and detection kit of a kind of pair of FMR1 gene 5 ' non-translational region CGG unit number of iterations |
CN108866176B (en) * | 2017-07-11 | 2021-09-14 | 北京阅微基因技术股份有限公司 | Detection system and detection kit for repeated number of CGG units in 5' untranslated region of FMR1 gene |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6871160B2 (en) | Methods for Identifying and Quantifying Nucleic Acid Expression, Splice Variants, Translocations, Copy Counts, or Methylation Changes | |
JP5789605B2 (en) | Chromosome aneuploidy detection method | |
US9719140B2 (en) | Direct molecular diagnosis of fetal aneuploidy | |
JP6739339B2 (en) | Covered sequence-converted DNA and detection method | |
JP6496665B2 (en) | Methods and primer sets for high-throughput PCR sequencing | |
CN102533985B (en) | Method for detecting deletion and/or duplication of exons in DMD gene | |
CN102808026B (en) | Primer, probe, fluorescent PCR kit and method for detecting polymorphism of human MTHFR (Methylene Tetrahydrofolate Reductase) gene | |
CN101611155B (en) | Diagnostic sequences for shrimp pathogens | |
CN111183229A (en) | Digital amplification using primers with limited nucleotide composition | |
CN115335536B (en) | Compositions and methods for on-the-fly nucleic acid detection | |
WO2013116039A1 (en) | Amplification primers and probes for detection of hiv-1 | |
WO2021177372A1 (en) | METHOD FOR DETECTING CORONAVIRUS (SARS-CoV-2) | |
US8153401B2 (en) | Method for direct amplification from crude nucleic acid samples | |
CN107083427B (en) | DNA ligase mediated DNA amplification technology | |
CN106834437A (en) | A kind of fragile X mental retardation quick detection kit | |
CN106868218B (en) | Multiple PCR kit for rapid diagnosis of viral encephalitis | |
JP5258760B2 (en) | Method for amplifying methylated or unmethylated nucleic acid | |
WO2007105673A1 (en) | Method for detection of mutant gene | |
CN108300776A (en) | Fragile X mental retardation fast screening reagent kit | |
US20240167107A1 (en) | Composition and method for nucleic acid detection | |
KR101912488B1 (en) | Molecular detection assay | |
WO2012083845A1 (en) | Methods for removal of vector fragments in sequencing library and uses thereof | |
JPWO2006070666A1 (en) | Simultaneous detection method of gene polymorphism | |
WO2018232597A1 (en) | Composition used for quantitative pcr amplification and application thereof | |
JP6976567B2 (en) | Sample preparation method for DNA methylation analysis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170613 |
|
WW01 | Invention patent application withdrawn after publication |